Gregoire Le Gal, MD PhD

MD, PhD
Ottawa Hospital Research Institute, University of Ottawa, Canada
Ottawa, Ontario, Canada

Dr Le Gal is a Professor of Medicine at the University Ottawa, a Senior Scientist and the Lead of the Thrombosis Research Group at the Ottawa Hospital Research Institute, and a Physician and Head of the Thrombosis Unit at the Ottawa Hospital, Ottawa, Canada. His holds the Chair on Diagnosis of Venous Thromboembolism at the University of Ottawa.

Presentation(s):

• OC 01.3 - Systemic and catheter-directed thrombolysis in high and intermediate-high risk pulmonary embolism: a systematic review with meta-analysis

  Saturday, June 24, 2023
  13:30 – 13:45 ET

• OC 11.6 - Diagnosis of Venous Thromboembolism

  Sunday, June 25, 2023
  10:45 – 12:00 ET

• OC 11.1 - Development and validation of a clinical prediction model for the diagnostic management of acute pulmonary embolism: an individual participant data meta-analysis

  Sunday, June 25, 2023
  10:45 – 11:00 ET

• OC 11.2 - Pulmonary embolism diagnostic strategies in patients with COPD exacerbation: post-hoc analysis of the PEP trial

  Sunday, June 25, 2023
  11:00 – 11:15 ET

• OC 11.3 - Association between body mass index and pulmonary embolism and performance of the age-adjusted D-dimer strategy in obese patients with suspected pulmonary embolism: a prospective management study

  Sunday, June 25, 2023
  11:15 – 11:30 ET

• OC 11.5 - Diagnostic strategies in patients on anticoagulation presenting with a suspicion of recurrent venous thromboembolism

  Sunday, June 25, 2023
  11:45 – 12:00 ET

• PB0486 - Effect of Age on Risk for Recurrent Venous Thromboembolism: A Systematic Review and Meta-Analysis

  Sunday, June 25, 2023
  18:30 – 19:30 ET

• OC 31.1 - Management and Outcomes of Anticoagulated Patients in Urgent Surgery: The PAUSE-ER Study

  Monday, June 26, 2023
  10:45 – 11:00 ET

• OC 32.2 - Risk of Venous Thromboembolism and Major Bleeding in Patients with Acute Medical Illness Receiving Thromboprophylaxis with Enoxaparin

  Monday, June 26, 2023
  11:00 – 11:15 ET

• OC 40.5 - Risk of All-Cause Mortality following Anticoagulant Cessation for Unprovoked Venous Thromboembolism: A Systematic Review and Meta-Analysis

  Monday, June 26, 2023
  15:45 – 16:00 ET

• PB1006 - Accuracy and interrater agreement of death event adjudications by physician trainees: Validation of the ISTH definition of pulmonary embolism-related death in an autopsy cohort

  Monday, June 26, 2023
  18:30 – 19:30 ET

• PB1008 - The diagnostic performance of the YEARS and PEGeD algorithm in patients with prior venous thrombosis suspected of pulmonary embolism

  Monday, June 26, 2023
  18:30 – 19:30 ET

• LB 02.2 - Prevention of Symptomatic Venous Thromboembolism with Low-Molecular-Weight Heparin in Hospitalized Older Adult Medical Patients: a Randomized Placebo-Controlled Trial

  Tuesday, June 27, 2023
  11:00 – 11:15 ET

• OC 63.4 - Prevalence of pulmonary embolism in patients with chronic obstructive pulmonary disease exacerbation in North America – a single center experience

  Tuesday, June 27, 2023
  15:30 – 15:45 ET

• PB1530 - Diagnostic strategies in postpartum individuals with suspected venous thromboembolism: A scoping review

  Tuesday, June 27, 2023
  18:30 – 19:30 ET